05 May 2005 : Original article
Long- and short-term effects of thyroxine on sphingolipid metabolism in rat liver
Nataliya A. BabenkoMed Sci Monit 2005; 11(5): BR131-138 :: ID: 16133
Abstract
Background:Thyroid hormones are well known as modulators of signal transduction. Early experiments showed that sustained elevation of diacylglycerol (DAG) and ceramide levels in liver cells of hypothyroid rats is an essential prerequisite for disturbances in agonist responsiveness of hepatocytes. In this paper the effects of thyroxine (L-T[sub]4[/sub]) on sphingolipid mass, synthesis, and degradation are investigated.Material/Methods:The experiments were performed on either [1[sup]14[/sup]C]CH[sub]3[/sub]COOH-labeled rat liver or hepatocytes and isolated liver cell plasma membranes. To determine sphingolipid synthesis and degradation in the liver, [[sup]14[/sup]C]palmitic acid, [methyl-[sup]14[/sup]C]-labeled sphingomyelin (SM), and phosphatidylcholine were used.Results:The administration of L-T[sub]4[/sub] to animals was accompanied by a time-dependent accumulation of newly synthesized ceramide, glucosyl ceramide, and SM in liver. In hyperthyroid liver, prominent ceramide accumulation and acidic SMase activation was found. The addition of hormone in a physiological dose to the incubation or perfusion medium led to a rapid stimulation of de novo ceramide synthesis, transient lipid accumulation in the liver, followed by SM synthase activation.Conclusions:Our results indicate that SMases, ceramide synthesis de novo, and SM synthase are under thyroid hormone control. The level of ceramide is markedly elevated in the hyperthyroid liver via the activation of acidic SMase and lipid synthesis de novo. In experiments in vitro, the hormone induces a short-lived accumulation of sphingolipid, probably due to its reduced efflux from the liver.
Keywords: Ceramides - metabolism, Sphingolipids - metabolism, Ceramides - metabolism, Kinetics, Liver - metabolism, Phosphatidylcholines - metabolism, Rats, Wistar, Sphingolipids - metabolism, Sphingomyelin Phosphodiesterase - metabolism, Sphingomyelins - metabolism, Thyroxine - pharmacology
565 7
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
28 May 2023 : Database Analysis
Scientometric and Visualized Analysis of Intravoxel Incoherent Motion Magnetic Resonance Imaging: 1988-2021Med Sci Monit In Press; DOI: 10.12659/MSM.938715
25 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
25 May 2023 : Review article
A Review of Preclinical and Clinical Studies in Support of the Role of Non-Steroidal Anti-Inflammatory Drug...Med Sci Monit In Press; DOI: 10.12659/MSM.940635
25 May 2023 : Clinical Research
Periapical Lesions and Missed Canals in Endodontically Treated Teeth: A Cone-Beam Computed Tomographic Stud...Med Sci Monit In Press; DOI: 10.12659/MSM.940533
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952